Effect of recombinant IL-10 on cultured fetal rat alveolar type II cells exposed to 65%-hyperoxia

Respiratory Research

Volumn 12, Issue , 2011, Pages

  Lee, Hyeon Soo ^a   Kim, Chun Ki ^a  

^a Kangwon National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CASPASE 3; INTERLEUKIN 8; LACTATE DEHYDROGENASE; RECOMBINANT INTERLEUKIN 10; VASCULOTROPIN; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; INTERLEUKIN 10; MESSENGER RNA; RECOMBINANT PROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE CHECKPOINT; CELL DAMAGE; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; FLOW CYTOMETRY; GENE EXPRESSION; HYPEROXIA; IN VITRO STUDY; INFLAMMATION; LUNG ALVEOLUS CELL TYPE 2; LUNG INJURY; NICK END LABELING; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CELL CULTURE; DRUG EFFECT; GENETICS; GESTATIONAL AGE; IMMUNOLOGY; LUNG ALVEOLUS; LUNG ALVEOLUS CELL; METABOLISM; NECROSIS; PATHOLOGY; PRENATAL DEVELOPMENT; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GESTATIONAL AGE; HYPEROXIA; IN SITU NICK-END LABELING; INTERLEUKIN-10; INTERLEUKIN-8; L-LACTATE DEHYDROGENASE; NECROSIS; PNEUMOCYTES; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79956288049     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-68     Document Type: Article

References (65)

1. Barazzone C, Horowitz S, Donati YR, Rodriguez I, Piguet PF. Oxygen toxicity in mouse lung: pathways to cell death. Am J Respir Cell Mol Biol 1998, 19:573-581.
2. Barazzone C, White CW. Mechanism of cell injury and death in hyperoxia: role of cytokines and Bcl-2 family proteins. Am J Respir Cell Mol Biol 2000, 22:535-542.
3. O'Reilly MA, Staversky RJ, Huyck HL, Watkins RH, LoMonaco MB, D'Angio CT, Baggs RB, Maniscalco WM, Pryhuber GS. Bcl-2 family gene expression during severe hyperoxia induced lung injury. Lab Invest 2000, 80:1845-1854. 10.1038/labinvest.3780195, 11140697.
4. Ward NS, Waxman AB, Homer RJ, Mantell LL, Einarsson O, Du Y, Elias JA. Interleukin-6 induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol 2000, 22:535-542.
5. Waxman AB, Einarsson O, Seres T, Knickelbein RG, Warshaw JB, Johnston R, Homer RJ, Elias JA. Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J Clin Invest 1998, 101:1970-1982. 10.1172/JCI1337, 508784, 9576762.
6. Rush MG, Hazinski TA. Current therapy of bronchopulmonary dysplasia. Clin Perinatol 1992, 19:563-590.
7. Jobe AH, Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum Dev 1998, 53:81-94. 10.1016/S0378-3782(98)00045-0, 10193929.
8. Lee PJ, Choi AM. Serial review: Role of reactive oxygen and nitrogen species (ROS/RNS) in lung injury and diseases. Free Rad Biol Med 2003, 35:341-350. 10.1016/S0891-5849(03)00279-X, 12899937.
9. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000, 117:1162-1172. 10.1378/chest.117.4.1162, 10767254.
10. Martin TR, Frevert CW. Innate immunity in the lungs. Am Thorac Soc 2005, 1:214-220.
11. Rahman I, Mulier B, Gilmour PS, Watchorn T, Donaldson K, Jeffery PK, MacNee W. Oxidant-mediated lung epithelial cell tolerance: the role of intracellular glutathione and NFkb. Biochemi Pharmacol 2001, 62:787-794.
12. Corne JG, Chupp CG, Lee RJ, Homer Z, Zhu Q, Chen B, Ma Y, Du F, Roux J, McArdle AB, Waxman J, Elias A. IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest 2000, 106:783-791. 10.1172/JCI9674, 381393, 10995789.
13. Horowitz S, Davis JM. From Lung injury when development is interrupted by premature birth. Growth and Development 1997, NY: New York, MacDonald JM, Dekker M.
14. Slutsky AS. Lung injury caused by mechanical ventilation. Chest 1999, 116:9S-15S. 10.1378/chest.116.suppl_1.9S, 10424561.
15. Bhandari V, Elias JA. Cytokines in tolerance to hyperoxia-induced injury in the developing and adult lung. Free Radic Biol Med 2006, 41:4-18. 10.1016/j.freeradbiomed.2006.01.027, 16781448.
16. Speer CP. Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonatal Med 2006, 11:354-362. 10.1016/j.siny.2006.03.004, 16702036.
17. Mourgeon E, Isowa N, Keshavjee S, Zhang X, Slutsky AS, Liu M. Mechanical stretch stimulates macrophage inflammatory protein-2 secretion from fetal rat lung cells. Am J Physiol Lung Cell Mol Physiol 2000, 279:L699-L706.
18. Shanley TP, Vasi N, Denenberg A. Regulation of chemokine expression by IL-10 in lung inflammation. Cytokine 2000, 12:1054-1064. 10.1006/cyto.1999.0655, 10880252.
19. Schultz C, Temming P, Bucsky P, Göpel W, Strunk T, Hätel C. Immature anti-inflammatory response in neonates. Clini Exp Immunol 2004, 135:130-136.
20. Jones CA, Cayabyab RG, Kwong KY, Stotts C, Wong B, Hamdan H, Minoo P, deLemos RA. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible development basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996, 39:966-975. 10.1203/00006450-199606000-00007, 8725256.
21. Kwong KY, Jones CA, Cayabyab R, Lecart C, Khuu N, Rhandhawa I, Hanley JM, Ramanathan R, deLemos RA, Minoo P. The effects of IL-10 on proinflammatory cytokine expression (IL-1beta and IL-8) in hyaline membrane disease (HMD). Clin Immunol Immunopathol 1998, 88:105-113. 10.1006/clin.1997.4510, 9683557.
22. Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003, 8:73-81. 10.1016/S1084-2756(02)00193-8, 12667832.
23. Coalson JJ. Pathology of bronchopulmonary dysplasia. Semin Perinatol 2006, 30:179-184. 10.1053/j.semperi.2006.05.004, 16860157.
24. Bourdon J, Boucherat O, Challey-Heu B, Delacourt C. Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res 2005, 57:38-46.
25. Maniscalo WM, Watkins RH, D'Angio CT, Ryan RM. Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. Am J Respir Cell Mol Biol 1997, 16:557-567.
26. Lee HS, Wang Y, Maciejewski BS, Esho K, Fulton C, Sharma S, Sanchez-Esteban J. Interleukin-10 protects cultured fetal rat type II epithelial cells from injury induced by mechanical stretch. Am J Physiol Lung Cell Mol Physiol 2008, 294:L225-L232.
27. Sanchez-Esteban J, Wang Y, Gruppuso PA, Rubin LP. Mechanical stretch induces fetal type II cell proliferation via an epidermal growth factor receptor-extracellular-regulated protein kinase signaling pathway. Am J Respir Cell Mol Biol 2004, 30:76-83.
28. Sanchez-Esteban J, Wang Y, Filardo EJ, Rubin LP, Ingber DE. Integrins β1, α6, and α3 contributes to mechanical strain-induced differentiation of fetal lung type II epithelial cells via distinct mechanisms. Am J Physiol Lung Cell Mol Physiol 2006, 290:343-350.
29. Deng HS, Mason N, Auten R. Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats. Am J Respir Crit Care Med 2000, 162:2316-2323.
30. Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, Zhang X, Matthay MA, Ware LB, Homer RJ, Lee PJ, Geick A, Fougerrolles AR, Elias JA. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 2006, 12:1286-1293. 10.1038/nm1494, 2768268, 17086189.
31. Dauger S, Ferkdadji L, Saumon G, Vardon G, Peuchmaur M, Gaultier C, Gallego J. Neonatal exposure to 65% oxygen durably impairs lung architecture and breathing pattern in adult mice. Chest 2003, 530-538.
32. Pagano A, Barazzone-Argiroff C. Alveolar cell death in hyperoxia-induced lung injury. Ann N Y Acad Sci 2003, 1010:405-416. 10.1196/annals.1299.074, 15033761.
33. Mantell LL, Lee PJ. Signal transduction pathways in hyperoixa-induced lung cell death. Mol Genet Metab 2000, 71:359-370. 10.1006/mgme.2000.3046, 11001828.
34. Scavo LM, Ertsey R, Chapin CJ, Allen L, Kitterman JA. Apoptosis in the development of rat and human fetal lungs. Am J Respir Cell Mol Biol 1998, 18:21-31.
35. Bustani P, Hodge R, Tellabati A, Li J, Pandya H, Kotecha S. Differential response of the epithelium and interstitium in developing human fetal lung explants to hyperoxia. Pediatr Res 2006, 59:383-388. 10.1203/01.pdr.0000198774.79043.5c, 16492976.
36. Haaften T, Byrne R, Bonnet S, Rochefort GY, Akabutu J, Bouchentouf M, Rey-Parra GJ, Haromy A, Eaton F, Chen M, Hashimoto K, Abley D, Korbutt G, Archer SL, Thebaud B. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 2009, 180:1131-1142. 10.1164/rccm.200902-0179OC, 19713449.
37. Huang B, Fu H, Yang M, Fang F, Kuang F, Xu F. Neuropeptide substance P attenuates hyperoxia-induced oxidative stress injury in type II alveolar epithelial cells via suppressing the activation of JNK pathway. Lung 2009, 187:421-426. 10.1007/s00408-009-9177-z, 19789913.
38. Iwata M, Myerson D, Torok-Storb B, Zager RA. An evaluation of renal tubular DNA laddering in response to oxygen deprivation and oxidant injury. J Am Soc Nephrol 1994, 5:1307-1311.
39. Slater AFC, Nobel CSI, Orrenius S. The role of intracellular oxidants in apoptosis. Biochem Biophys Acta Mol Basis Dis 1994, 1271:59-62.
40. Ueda N, Shah SV. Endonuclease-induced DNA damage and cell death in oxidant injury to renal tubular epithelial cells. J Clin Invest 1992, 90:2593-2597. 10.1172/JCI116154, 443419, 1334979.
41. Barazzone C, Donati YR, Rochat AF, Vesin C, Kan CD, Pache JC, Piguet PF. Keratinocyte growth factor protects alveolar epithelium and endothelium from oxygen-induced injury in mice. Am J Pathol 1999, 154:1479-1487. 10.1016/S0002-9440(10)65402-8, 1866589, 10329601.
42. Kanduc D, Mittelman A, Serpico R, Sinigaglia E, Sinha AA, Natale C, Santacroce R, Di Corcia MG, Lucchese A, Dini L, Pani P, Santacroce S, Simone S, Bucci R, Farber E. Cell death: apoptosis versus necrosis (review). Intl J Oncol 2002, 21:165-170.
43. Kroemer G, Dallaporta B, Resche-Rigon M. Mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 1998, 60:619-642. 10.1146/annurev.physiol.60.1.619, 9558479.
44. Saraste A, Pulkki K. Morphologic and biological hallmarks of apoptosis. Cardiovasc Res 2000, 45:528-537. 10.1016/S0008-6363(99)00384-3, 10728374.
45. Van Cruchten S, Van Den Broeck W. Morphologial and biochemical aspects of apoptosis, oncosis and apoptosis. Am J Physiol 1999, 276:G1-6.
46. Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami N, Loeffler M, Costantini P, Ferri KF, Irinopoulou T, Prévost MC, Brothers G, Mak TW, Penninger J, Earnshaw WC, Kroemer G. Two distinct pathways leading to nuclear apoptosis. J Exp Med 2000, 192:571-580. 10.1084/jem.192.4.571, 2193229, 10952727.
47. Lee HS, Kim CK. Cathepsin-B is activated as an executive protease in fetal alveolar type II epithelial cells exposed to hyperoxia. Exp Mol Med 2011, 43:223-229. 10.3858/emm.2011.43.4.027, 3085741, 21415591.
48. Alphonse RS, Vadivel A, Coltan L, Eaton F, Barr AJ, Dyck JRB, Thebaud B. Activation of Akt protects alveoli from neonatal oxygen-induced lung injury. Am J Respir Cell Mol Biol 2011, 44:146-154. 10.1165/rcmb.2009-0182OC, 20348209.
49. Esquibies AE, Bazzy-Asaad A, Ghassemi F, Nishio H, Karihaloo A, Cantley LG. VEGF attenuates hyperoxic injury through decreased apoptosis in explanted rat embryonic lung. Pediatr Res 2008, 63:20-25. 10.1203/PDR.0b013e31815b4857, 18043510.
50. Yee M, Vitello PF, Roper JM, Staversky R, Wright TW, McGrath-Morrow SA, Maniscalo WM, Finkelstein JN, O'Reilly MA. Type II epithelial cells are critical target for hyperoxia-mediated impairment of postnatal lung developmemt. Am J Physiol Lung Cell Mol Physiol 2006, 291:L1101-1111. 10.1152/ajplung.00126.2006, 16861382.
51. Muniscalo WM, Watkins RH, D'Angio CT, Ryan RM. Hyperoxic lung injury decreases alveolar epithelial cell exposure of vascular endothelial growth factor (VEGF) in neonatal lung. Am J Respir Cell Mol Biol 1997, 16:557-567.
52. Gebb SA, Shannon JM. Tissue interactions mediate early events in pulmonary vasculogenesis. Dev Dyn 2000, 217:159-169. 10.1002/(SICI)1097-0177(200002)217:2<159::AID-DVDY3>3.0.CO;2-9, 10706140.
53. Voelkel NF, William V R, Rubin MT. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 2006, 290:209-221.
54. Maniscalco WM. Differential expression of VEGF mRNA splice variants in newborn and adult hyperoxic lung injury. Am J Physiol Lung cell Mol Physiol 1999, 276:L858-L867.
55. Been JV, Debeer A, van Iwaarden JF, Kloosterboer N, Passos VL, Naulaers G, Zimmermann LJ. Early alterations of growth factor patterns in bronchopulmonary dysplasia. Pediatr Res 2010, 67:83-89. 10.1203/PDR.0b013e3181c13276, 19770691.
56. Thickett DR, Armstrong L, Christie SJ, Milar AB. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 164:1601-1605.
57. Thickett DR, Armstrong L, Milar AB. A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med 2002, 166:1332-1337. 10.1164/rccm.2105057, 12421742.
58. Carne J, Chupp G, Lee CG, Homer RJ, Zhu Z, Chen Q, Ma B, Du Y, Roux F, McArdle J, Waxman AB, Elias JA. IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest 2000, 106:783-791. 10.1172/JCI9674, 381393, 10995789.
59. Pryhuber G, O'Brien D, Baggs R, Phipps R, Huyck H, Sanz I, Nahm M. Ablation of tumor necrosis factor receptor type I (p55) alters oxygen-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2000, 278:L1082-1090.
60. Guthmann F, Wissel H, Schachtrup C, Tölle A, Rüdiger M, Spener F, Rüstow B. Inhibition of TNFalpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells. Resp Res 2005, 6:10-25.
61. Wendel M, Giessmann U, Behrend P, Augstein A, Koslowski R, Haufe D, Kasper M, Koch T. Inflammatory-activated microvascular endothelial cells regulate interleukin-8 and monocyte chemoattractant protein-1 expression of A549 cells in a paracrine fashion. Exp Lung Res 2008, 34:85-100. 10.1080/01902140701807910, 18266131.
62. Zhu Y, Miller TL, Singhaus CJ, Shaffer TH, Chidekel A. Effects of oxygen concentration and exposure time on cultured human airway epithelial cells. Pediatr Crit Care Med 2008, 9:224-229. 10.1097/PCC.0b013e318166fbb5, 18477937.
63. Zhong J, Deaciuc IV, Burikhanov R, de Villers WJ. Lipopolysaccharide-induced liver apoptosis is increased in interleukin-10 knockout mice. Biochemi Biophys Acta 2006, 1762:468-477.
64. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 2000, 279:1005-1028.
65. McAuliffe PF, Murday ME, Efron PA, Scumpia PO, Ungaro R, Abouhamze A, Tannahill CL, Hutchins B, Laface D, Moldawer LL. Dose-dependent improvements in outcome with adenoviral expression of interleukin-10 in a murine model of multisystem organ failure. Gene Ther 2006, 13:276-282. 10.1038/sj.gt.3302600, 16251998.